Skip to main content
. 2014 Apr 14;20(14):3825–3834. doi: 10.3748/wjg.v20.i14.3825

Table 2.

Characteristics of selected fecal occult blood test colorectal cancer screening projects including personal invitations

Country Age group (yr), test Time period Procedure in personal invitation Participation rate Source
Studies and pilot projects
England 50-69 2000-2004 Centralized invitations by the screening unit F: 59% Weller et al[67], 2007
gFOBT Sending fecal occult blood test (FOBT) test kits SM: 48% UKCRCSPG[66], 2004
SW: 56%
France 50-74 2003-2006 Centralized invitations according to sickness fund database files FM: 54% Denis et al[59], 2007
gFOBT Invitation to general practitioners (GP), reminder after 6 mo, FOBT kit reminder 4 mo later FW: 57%
Exclusions by GP: serious illness, recent colorectal cancer (CRC) screening, high CRC risk
Netherlands 50-74 2006-2007 Centralized invitations gFOBT: Hol et al[60], 2010
gFOBT, FIT Exclusions: Inflammatory bowel disease (IBD), CRC, recent CRC screening 50%
Pre-invitation, sending test kits after 2 wk, reminder after 6 wk FIT: 62%
Scotland 50-69 2000-2007 Centralized invitations by the screening center FM: 50%, FW: 60% Steele et al[65], 2009
gFOBT Sending FOBT test kits SM: 49%, SW: 57%
Reminder-second kit-after 6 wk (kit in first round only)
Spain 50-69 Since 2000 Centralized invitations FM: 17%, FW: 18% Peris et al[64], 2007
gFOBT Exclusions: CRC, adenoma, high CRC risk SM: 21%, SW: 24%
Invitation-reply-sending test kit, reminder after 6 wk
Population-based screening programs
England 60-69 Since 2006 Centralized invitations by the screening center M: 50% Logan et al[61], 2012
gFOBT People registered with a GP practice W: 54%
Sending FOBT test kits
Finland 60-69 Since 2004 Centralized invitations by the national screening center FM: 62%, FW: 77% Malila et al[48], 2011
gFOBT using Population Register Center SM: 68%, SW: 80% Malila et al[63], 2008
Sending FOBT test kits Malila et al[62], 2005

F: First round of screening; S: Second round of screening; M: Men; W: Women; gFOBT: Guaiac fecal occult blood test; FIT: Fecal immunochemical test.